Completed NA INTERVENTIONAL 1-arm NCT02866240

Safety and Therapeutic Measures of Tdcs in Patients With Refractory Focal Epilepsy

Safety and Therapeutic Measures of Cathodal Transcranial Direct Current Stimulation (Tdcs) in Patients With Refractory Focal Epilepsy

Sponsor: Beth Israel Deaconess Medical Center

Conditions Refractory Epilepsy

Interventions Cathodal Transcranial Direct Current Stimulation (tDCS).

Updated 10 times since 2017 Last updated: Jan 7, 2021 Started: Sep 21, 2017 Primary completion: Dec 31, 2019 Completion: Dec 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Refractory Epilepsy, this trial is completed. The trial is conducted by Beth Israel Deaconess Medical Center and has accumulated 10 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Feb 2021 — Jul 2024 [monthly]

Completed NA

Status: Unknown Status → Completed
Jan 2021 — Feb 2021 [monthly]

Unknown Status NA
Sep 2020 — Jan 2021 [monthly]

Unknown Status NA

▶ Show 5 earlier versions

Aug 2019 — Sep 2020 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jun 2018 — Aug 2019 [monthly]

Recruiting NA
Aug 2017 — Jun 2018 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Feb 2017 — Aug 2017 [monthly]

Not Yet Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beth Israel Deaconess Medical Center
Boston Children's Hospital
Neuroelectrics Corporation

Data source: Neuroelectrics Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States